Company intelligence / Profile preview

Kyongbo Pharmaceutical Co., Ltd

Asan-si, Chungcheongnam-do, South Koreakbpharma.co.kr ↗
Ownership
Public · 214390.KS
Employees
~300
Development stage
Commercial
01

Overview

Kyongbo Pharmaceutical is a leading South Korean API manufacturer with cGMP certifications from FDA, EDQM, PMDA Japan, CFDA China. It produces various antibiotics especially cephalosporins along with finished dosage forms. It has expanded into CDMO services for high potency compounds. The company has partnered to distribute Can-Fite’s Phase III psoriasis drug Piclidenoson in South Korea. They export to over thirty countries globally with annual exports around $85 million worth of products. Their R&D focuses on developing new pharmaceutical substances while maintaining strong manufacturing capabilities. They have multiple plants dedicated to general APIs, sterile injectables, anticancer APIs etc.

Therapeutic areas
OncologyDermatologyGastroenterologyCardiovascularInfectious Diseases
Modalities
Small moleculesActive pharmaceutical ingredients (APIs)Cephalosporin antibioticsAntihyperlipidemic agentsAnti-cancer drugsFinished dosage formsAnesthetic drugsCardiovascular drugsDigestive drugsAntibiotic drugsSterile injectablesHigh potency APIsMedical devicesPortable X-ray machinesUltrasonic diagnostic equipmentExtracorporeal shockwave therapy devices
Industry
Contract Manufacturing Organization
02

Drug pipeline

1 asset

CKD-510

Development
Indications
Neurological diseases, Cardiovascular diseases
03

Partnerships

Can-Fite BioPharma Ltd — distribution agreement for psoriasis drug Piclidenoson in South KoreaFunding provided to Pharosgen Co., Ltd.Licensing deals involving other companies like AFT Pharmaceuticals Limited

Beyond the preview

Go deeper on Kyongbo Pharmaceutical Co., Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kyongbo Pharmaceutical Co., Ltd.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call